Skip to content

Study on the diagnostic value of intestinal flora - bile acid metabolism profile in the classification of aldehydes

Study on the diagnostic value of intestinal flora - bile acid metabolism profile in the classification of aldehydes

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1900027374
Enrollment
Unknown
Registered
2019-11-11
Start date
2020-01-01
Completion date
Unknown
Last updated
2019-11-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adrenal Disease

Interventions

Gold Standard:At present, the main classification methods are adrenal CT and bilateral adrenal vein (AVS).
flora,&#32
blood&#32
acid.

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 65 Years

Inclusion criteria

Inclusion criteria: (1) the United States in 2016 "the original aldehyde disease diagnosis and treatment guidelines" and the Chinese medical association of endocrinology branch to complete Chinese original aldehyde disease expert consensus recommendations: ARR screening positive patients need to accept one or more than 1 confirmatory test to confirm or exclude the diagnosis of PA, but for the spontaneous hypokalemia, plasma renin below detection limit or the plasma aldosterone levels greater than 20 ng/dL (550 pmol/L) in patients with confirmed that don't have to test. (2) 28 kg/m2 or higher BMI; 20 kg/m2 or (3) through medical history inquiry, physical examination, electrocardiogram examination, skull imaging examination and other data exclude obvious cardiovascular and cerebrovascular diseases; (4) mental normal, after informed consent to participate in the research.

Exclusion criteria

Exclusion criteria: (1) with acute and chronic liver, renal insufficiency, cholestasis;Acute infectious disease;Malignant tumor;Thyroid disease;Diseases of the immune system;Patients with gastrointestinal diseases; (2) with serious mental illness and cognitive impairment; (3) treatment before the use of drugs that have an impact on this study; (4) the study of drug allergy, drug side effects can not tolerate, do not want to take biological specimens; (5) pregnant and lactating women; (6) the use of antibiotics, probiotics and other intestinal flora intervention drugs, health care products, etc..

Design outcomes

Primary

MeasureTime frame
gut microbiota16sRNA;Fecal bile acids;Blood bile acid;SEN, SPE, ACC, AUC of ROC;

Countries

China

Contacts

Public ContactChen Tao

Department of Endocrinology, West China Hospital, Sichuan University

dr.chentao@qq.com+86 18980606758

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026